Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Intuitive Surgical Inc(ISRG US)

$443.59+3.700.84%Ext:$442.93-0.660.15%(After Hours · 22:05:01 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Intuitive Surgical Inc(ISRG US)

$443.59+3.700.84%Ext:$442.93-0.660.15%(After Hours · 22:05:01 UTC)
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
ISRG US​
Ask AI
ISRG US​
Ask AI

Intuitive Surgical Inc — Company Profile

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sector
Materials
Industry
Paper & Forest Products
Exchange
UQ
CEO
David J. Rosa
Headquarters
Sunnyvale, CA, US
IPO Date
Jun 16, 2000
Employees
17,021
Website
www.intuitive.com

Key Metrics

Price
$391.95
Market Cap
$138.47B
Revenue (TTM)
$2.89B
Net Income (TTM)
$818.10M
EPS (TTM)
2.32
P/E (TTM)
46.48
P/B (TTM)
7.57
Dividend Yield
0.00%
ROE (TTM)
4.70%
ROA (TTM)
4.08%
Operating Margin
30.87%
Beta
0.80

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Website
www.intuitive.com
Location
Sunnyvale, CA, US
Phone408 523 2100
Employees17,021
CEODavid J. Rosa
Sector
Materials
Industry
Paper & Forest Products
IPO DateJun 16, 2000

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(2.4K)

Expand
  • Form 4LOEB GARY12 Nov
  • Form 144LOEB GARY10 Nov
  • Form 4GUTHART GARY S5 Nov
  • Form 4BARRATT CRAIG H5 Nov
  • Form 144BARRATT CRAIG H4 Nov
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers2 Nov
  • Form 4Brosius Mark2 Nov
  • Form 4Widman Fredrik2 Nov
  • Form 144Widman Fredrik30 Oct
  • Form 4Brosius Mark28 Oct
  • Form 4BARRATT CRAIG H26 Oct
  • Form 4Widman Fredrik26 Oct
  • Form 4WADORS PATRICIA L26 Oct
  • Form 4GUTHART GARY S26 Oct
  • Form 144Widman Fredrik23 Oct
  • Form 144GUTHART GARY S23 Oct
  • Form 144BARRATT CRAIG H23 Oct
  • Form 144WADORS PATRICIA L23 Oct
  • 10-QQ3ended 30 Sept 202621 Oct
  • 8-KResults of Operations and Financial Condition20 Oct

News

  • Intuitive Surgical: Why I Remain Bullish Despite Cutting My Price Target12 Nov
  • Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet12 Nov
  • ISRG Agrees to $450M Settlement: What Does It Mean for Investors?12 Nov
  • Is Intuitive Surgical (ISRG) a Solid Growth Stock? 3 Reasons to Think "Yes"11 Nov
  • Nasdaq-100 Correction: 2 Proven Winners That Can Buck Historic Volatility10 Nov
  • ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?9 Nov
  • Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year?9 Nov
  • Calamos Wealth Management LLC Sells 24,057 Shares of Intuitive Surgical, Inc. $ISRG9 Nov
  • Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street's Sell-Off Misses the Point.8 Nov
  • Hims & Hers Health vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy for 2027?6 Nov
  • Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know6 Nov
  • Intuitive Surgical, Inc. $ISRG Shares Bought by Integrity Alliance LLC.6 Nov
  • ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?5 Nov
  • 2 Growth Stocks to Buy in November Without Any Hesitation5 Nov
  • Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Momentum Stock4 Nov
  • Intuitive Appoints Aaron Martin to its Board of Directors2 Nov
  • Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.1 Nov
  • Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?30 Oct
  • ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?29 Oct
  • Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock29 Oct

Mentions in Filings

  • **The Fund is not suitable for all investors. The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leverage (2X) investment results, understand the risks associated with the use of leverage, and are willing to monitor their portfolios frequently. The Fund is not intended to be used by, and is not appropriate for, investors who do not intend to actively monitor and manage th …
    GraniteShares ETF TrustIntuitive Surgical Inc·497K - Form 497K - Summary prospectus·28 Oct·28 Oct
  • … ory of investment experience as well as his experience with start-ups and technology companies. **Dr. Catherine Mohr** has served as a member of our board of directors since December 2021. Dr. Mohr has been with <strong>Intuitive Surgical, Inc.</strong>, a developer and manufacturer of surgical robotic products designed to improve clinical outcomes of patients, since May 2016, where she has served in various executive roles, including as vice president, strategy …
    ZincFive, Inc.Intuitive Surgical Inc·S-4/A - Registration statement (business combination, amendment)·Q4 26·21 Oct
  • … 023, where he served in various senior-level sales positions, including most recently as Vice President Sales, Americas APAC from July 2022 to July 2023. Prior to that he served in various sales-related positions at <strong>Intuitive Surgical</strong>, Mpathy Medical, Cook Medical and Eli Lilly & Company. Mr. Miele holds a B.S. in Finance and Marketing from Northeastern University. 17 --- TABLE OF CONTENTS COMPENSATION DISCUSSION AND ANALYSIS Introduction T …
    ACCURAY INCIntuitive Surgical Inc·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … elman brings extensive experience in advising and investing in emerging growth companies in the technology, media, medical device and biotech sectors. Mr. Adelman was the lead banker in Computer Motion’s merger with <strong>Intuitive Surgical</strong> and was a member of the board of directors of Pharmacyclics prior to its acquisition by Abbvie for over $20 billion. Currently, Mr. Adelman serves as a member of the board of directors of Trio-Tech International, a …
    FullPAC, Inc.Intuitive Surgical Inc·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·9 Oct
  • … EC under the Exchange Act can be located by reference to its SEC file number: 000-51222, or its CIK Code: 0001093557. Its common stock is listed on the Nasdaq Global Select Market under the ticker symbol “DXCM.” <strong>Intuitive Surgical, Inc.</strong> develops, manufactures, and markets surgery products. Information filed by the company with the SEC under the Exchange Act can be located by reference to its SEC file number: 000-30713, or its CIK Code: 000103526 …
    BANK OF MONTREAL /CAN/Intuitive Surgical Inc·FWP - ELN 6351·Q4 26·6 Oct
  • … tt Laboratories | 109.290 | 7,103.85 | | | 59 | DexCom, Inc. | 80.345 | 4,740.36 | | | 68 | Edwards Lifesciences Corporation | 105.810 | 7,195.08 | | | 7 | IDEXX Laboratories, Inc. | 702.590 | 4,918.13 | | | 16 | <strong>Intuitive Surgical, Inc.</strong> | 449.530 | 7,192.48 | | | 30 | Stryker Corporation | 318.790 | 9,563.70 | | | | **Health Care Facilities - 5.95%** | | | | | 50 | Encompass Health Corporation | 142.240 | 7,112.00 | | | 14 | HCA Healthcare, Inc. …
    Invesco Unit Trusts Series 2507Intuitive Surgical Inc·487 - Form 487 - VKUT 2507·Q4 26·12 Nov

Key Stats

Trading

Px/Chg 1D$391.95 / -2.32%
Avg Volume2.12M
Beta0.80
Mkt Cap138.47B
FD Mkt Cap132.21B

Float

Shrs Out/Float353.28M / 351.21M
Short Float0.02%
Days to Cover2.69
Stock Repurchased$1.12B

Current Valuation

EV129.84B
EV/EBITDA32.28
EV/Sales12.90
P/B7.57
P/S13.09
FCF Yield0.58%
ROE4.70%
ROA4.08%
Current Ratio6.03

Estimates

P/E46.48
Est P/E0.00
Est EPS2.12
Est PEG0.00

Valuation

Metric5Yr AvgApr '23Apr '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings119.4280.3272.7973.21201.51169.25
Price / Sales31.9117.0718.3720.3655.8847.87
Price / Book Value9.279.629.8310.358.997.57
Price / Free Cash Flow161.29110.81174.58130.43219.40171.24
ENTERPRISE VALUE METRICS
Enterprise Value137,643.6104,690.8128,207.3168,262.9157,215.3129,841.8
Enterprise Value / Sales30.9416.8318.0020.1554.8544.89
Enterprise Value / EBITDA91.8753.8859.1159.86133.63152.84
Enterprise Value / EBIT75.0266.3872.5671.63164.520.00

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue15.2%5,710.16,222.27,124.18,352.110,064.7
Gross Income13.8%3,958.54,196.04,729.55,634.26,642.3
EBITDA17%2,131.21,942.92,169.02,810.93,988.5
EBIT16.1%1,821.01,577.11,766.82,348.93,311.4
Net Income13.8%1,704.61,322.31,798.02,322.62,856.0
EPS (Diluted)14%4.663.655.036.427.87
BALANCE SHEET
Cash & ST Inv8.8%4,230.94,117.95,223.24,013.35,934.9
Total Assets11.1%13,555.012,974.015,441.518,838.620,631.2
Total Liabilities13.8%1,603.51,861.42,044.22,309.02,689.5
Total Shareholder Equity10.5%11,951.511,041.913,307.616,433.717,824.0
CASH FLOW
Net Operating Cash Flow9.7%2,089.41,490.81,813.82,415.03,030.5
Cap Ex11.2%-353.5-532.4-1,064.2-1,111.2-539.8
Free Cash Flow9.4%1,735.9958.4749.61,303.82,490.7

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)448.49
Basic Shares353.28
Market Cap158,441.7
Diluted Shares351.60
Fully Diluted Shares Outstanding351.60
Fully Diluted Market Cap157,689.1
+Consolidated Debt-
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-2,978.1
−Short-term Investments-1,064.4
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest131.6
+Pension Liabilities—
Enterprise Value155,595.2

Segment data

Revenue

by Products and services

  • Instruments And Accessories60%
  • Systems25%
  • Services16%

Revenue

by Geography

  • Geographic Distribution, Domestic68%
  • Geographic Distribution, Foreign32%

Related companies

Amgen Inc

AMGN US

Gilead Sciences, Inc.

GILD US

Moderna, Inc.

MRNA US

Argenx Se

ARGX US

Edwards Lifesciences Corporation

EW US

Revolution Medicines, Inc.

RVMD US

Biogen Inc.

BIIB US

BioNTech SE

BNTX US

STERIS plc

STE US

Nordson Corp

NDSN US

Tyson Foods, Inc.

TSN US

Zimmer Biomet Holdings Inc.

ZBH US

Intuitive Surgical Inc — Company Profile

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sector
Materials
Industry
Paper & Forest Products
Exchange
UQ
CEO
David J. Rosa
Headquarters
Sunnyvale, CA, US
IPO Date
Jun 16, 2000
Employees
17,021
Website
www.intuitive.com

Key Metrics

Price
$391.95
Market Cap
$138.47B
Revenue (TTM)
$2.89B
Net Income (TTM)
$818.10M
EPS (TTM)
2.32
P/E (TTM)
46.48
P/B (TTM)
7.57
Dividend Yield
0.00%
ROE (TTM)
4.70%
ROA (TTM)
4.08%
Operating Margin
30.87%
Beta
0.80

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Website
www.intuitive.com
Location
Sunnyvale, CA, US
Phone408 523 2100
Employees17,021
CEODavid J. Rosa
Sector
Materials
Industry
Paper & Forest Products
IPO DateJun 16, 2000

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(2.4K)

Expand
  • Form 4LOEB GARY12 Nov
  • Form 144LOEB GARY10 Nov
  • Form 4GUTHART GARY S5 Nov
  • Form 4BARRATT CRAIG H5 Nov
  • Form 144BARRATT CRAIG H4 Nov
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers2 Nov
  • Form 4Brosius Mark2 Nov
  • Form 4Widman Fredrik2 Nov
  • Form 144Widman Fredrik30 Oct
  • Form 4Brosius Mark28 Oct
  • Form 4BARRATT CRAIG H26 Oct
  • Form 4Widman Fredrik26 Oct
  • Form 4WADORS PATRICIA L26 Oct
  • Form 4GUTHART GARY S26 Oct
  • Form 144Widman Fredrik23 Oct
  • Form 144GUTHART GARY S23 Oct
  • Form 144BARRATT CRAIG H23 Oct
  • Form 144WADORS PATRICIA L23 Oct
  • 10-QQ3ended 30 Sept 202621 Oct
  • 8-KResults of Operations and Financial Condition20 Oct

News

  • Intuitive Surgical: Why I Remain Bullish Despite Cutting My Price Target12 Nov
  • Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet12 Nov
  • ISRG Agrees to $450M Settlement: What Does It Mean for Investors?12 Nov
  • Is Intuitive Surgical (ISRG) a Solid Growth Stock? 3 Reasons to Think "Yes"11 Nov
  • Nasdaq-100 Correction: 2 Proven Winners That Can Buck Historic Volatility10 Nov
  • ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?9 Nov
  • Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year?9 Nov
  • Calamos Wealth Management LLC Sells 24,057 Shares of Intuitive Surgical, Inc. $ISRG9 Nov
  • Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street's Sell-Off Misses the Point.8 Nov
  • Hims & Hers Health vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy for 2027?6 Nov
  • Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know6 Nov
  • Intuitive Surgical, Inc. $ISRG Shares Bought by Integrity Alliance LLC.6 Nov
  • ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?5 Nov
  • 2 Growth Stocks to Buy in November Without Any Hesitation5 Nov
  • Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Momentum Stock4 Nov
  • Intuitive Appoints Aaron Martin to its Board of Directors2 Nov
  • Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.1 Nov
  • Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?30 Oct
  • ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?29 Oct
  • Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock29 Oct

Mentions in Filings

  • **The Fund is not suitable for all investors. The Fund is designed to be utilized only by knowledgeable investors who understand the potential consequences of seeking daily leverage (2X) investment results, understand the risks associated with the use of leverage, and are willing to monitor their portfolios frequently. The Fund is not intended to be used by, and is not appropriate for, investors who do not intend to actively monitor and manage th …
    GraniteShares ETF TrustIntuitive Surgical Inc·497K - Form 497K - Summary prospectus·28 Oct·28 Oct
  • … ory of investment experience as well as his experience with start-ups and technology companies. **Dr. Catherine Mohr** has served as a member of our board of directors since December 2021. Dr. Mohr has been with <strong>Intuitive Surgical, Inc.</strong>, a developer and manufacturer of surgical robotic products designed to improve clinical outcomes of patients, since May 2016, where she has served in various executive roles, including as vice president, strategy …
    ZincFive, Inc.Intuitive Surgical Inc·S-4/A - Registration statement (business combination, amendment)·Q4 26·21 Oct
  • … 023, where he served in various senior-level sales positions, including most recently as Vice President Sales, Americas APAC from July 2022 to July 2023. Prior to that he served in various sales-related positions at <strong>Intuitive Surgical</strong>, Mpathy Medical, Cook Medical and Eli Lilly & Company. Mr. Miele holds a B.S. in Finance and Marketing from Northeastern University. 17 --- TABLE OF CONTENTS COMPENSATION DISCUSSION AND ANALYSIS Introduction T …
    ACCURAY INCIntuitive Surgical Inc·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … elman brings extensive experience in advising and investing in emerging growth companies in the technology, media, medical device and biotech sectors. Mr. Adelman was the lead banker in Computer Motion’s merger with <strong>Intuitive Surgical</strong> and was a member of the board of directors of Pharmacyclics prior to its acquisition by Abbvie for over $20 billion. Currently, Mr. Adelman serves as a member of the board of directors of Trio-Tech International, a …
    FullPAC, Inc.Intuitive Surgical Inc·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·9 Oct
  • … EC under the Exchange Act can be located by reference to its SEC file number: 000-51222, or its CIK Code: 0001093557. Its common stock is listed on the Nasdaq Global Select Market under the ticker symbol “DXCM.” <strong>Intuitive Surgical, Inc.</strong> develops, manufactures, and markets surgery products. Information filed by the company with the SEC under the Exchange Act can be located by reference to its SEC file number: 000-30713, or its CIK Code: 000103526 …
    BANK OF MONTREAL /CAN/Intuitive Surgical Inc·FWP - ELN 6351·Q4 26·6 Oct
  • … tt Laboratories | 109.290 | 7,103.85 | | | 59 | DexCom, Inc. | 80.345 | 4,740.36 | | | 68 | Edwards Lifesciences Corporation | 105.810 | 7,195.08 | | | 7 | IDEXX Laboratories, Inc. | 702.590 | 4,918.13 | | | 16 | <strong>Intuitive Surgical, Inc.</strong> | 449.530 | 7,192.48 | | | 30 | Stryker Corporation | 318.790 | 9,563.70 | | | | **Health Care Facilities - 5.95%** | | | | | 50 | Encompass Health Corporation | 142.240 | 7,112.00 | | | 14 | HCA Healthcare, Inc. …
    Invesco Unit Trusts Series 2507Intuitive Surgical Inc·487 - Form 487 - VKUT 2507·Q4 26·12 Nov

Key Stats

Trading

Px/Chg 1D$391.95 / -2.32%
Avg Volume2.12M
Beta0.80
Mkt Cap138.47B
FD Mkt Cap132.21B

Float

Shrs Out/Float353.28M / 351.21M
Short Float0.02%
Days to Cover2.69
Stock Repurchased$1.12B

Current Valuation

EV129.84B
EV/EBITDA32.28
EV/Sales12.90
P/B7.57
P/S13.09
FCF Yield0.58%
ROE4.70%
ROA4.08%
Current Ratio6.03

Estimates

P/E46.48
Est P/E0.00
Est EPS2.12
Est PEG0.00

Valuation

Metric5Yr AvgApr '23Apr '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings119.4280.3272.7973.21201.51169.25
Price / Sales31.9117.0718.3720.3655.8847.87
Price / Book Value9.279.629.8310.358.997.57
Price / Free Cash Flow161.29110.81174.58130.43219.40171.24
ENTERPRISE VALUE METRICS
Enterprise Value137,643.6104,690.8128,207.3168,262.9157,215.3129,841.8
Enterprise Value / Sales30.9416.8318.0020.1554.8544.89
Enterprise Value / EBITDA91.8753.8859.1159.86133.63152.84
Enterprise Value / EBIT75.0266.3872.5671.63164.520.00

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue15.2%5,710.16,222.27,124.18,352.110,064.7
Gross Income13.8%3,958.54,196.04,729.55,634.26,642.3
EBITDA17%2,131.21,942.92,169.02,810.93,988.5
EBIT16.1%1,821.01,577.11,766.82,348.93,311.4
Net Income13.8%1,704.61,322.31,798.02,322.62,856.0
EPS (Diluted)14%4.663.655.036.427.87
BALANCE SHEET
Cash & ST Inv8.8%4,230.94,117.95,223.24,013.35,934.9
Total Assets11.1%13,555.012,974.015,441.518,838.620,631.2
Total Liabilities13.8%1,603.51,861.42,044.22,309.02,689.5
Total Shareholder Equity10.5%11,951.511,041.913,307.616,433.717,824.0
CASH FLOW
Net Operating Cash Flow9.7%2,089.41,490.81,813.82,415.03,030.5
Cap Ex11.2%-353.5-532.4-1,064.2-1,111.2-539.8
Free Cash Flow9.4%1,735.9958.4749.61,303.82,490.7

Enterprise Value Bridge

Millions USD13 Nov '26
Price (As of 13 Nov '26)448.49
Basic Shares353.28
Market Cap158,441.7
Diluted Shares351.60
Fully Diluted Shares Outstanding351.60
Fully Diluted Market Cap157,689.1
+Consolidated Debt-
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-2,978.1
−Short-term Investments-1,064.4
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest131.6
+Pension Liabilities—
Enterprise Value155,595.2

Segment data

Revenue

by Products and services

  • Instruments And Accessories60%
  • Systems25%
  • Services16%

Revenue

by Geography

  • Geographic Distribution, Domestic68%
  • Geographic Distribution, Foreign32%

Related companies

Amgen Inc

AMGN US

Gilead Sciences, Inc.

GILD US

Moderna, Inc.

MRNA US

Argenx Se

ARGX US

Edwards Lifesciences Corporation

EW US

Revolution Medicines, Inc.

RVMD US

Biogen Inc.

BIIB US

BioNTech SE

BNTX US

STERIS plc

STE US

Nordson Corp

NDSN US

Tyson Foods, Inc.

TSN US

Zimmer Biomet Holdings Inc.

ZBH US